Pablo J. Cagnoni - Concepedia

Author

Pablo J. Cagnoni

Also Known As

P Cagnoni, P J Cagnoni, P. Cagnoni, P. J. Cagnoni, PABLO J. CAGNONI, Pablo Cagnoni, Pablo J Cagnoni, Pablo J. Cagnoni, Pablo J. Cagnoni, MD

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver University of Colorado Health University of Colorado Boulder The University of Texas MD Anderson Cancer Center Emory University

About

Pablo J. Cagnoni is an author at University of Colorado Denver specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	470
2	Health Sciences	4	4	204
3	Cell Biology	3	3	216
4	Public Health	1	1	10
5	Blood Transplantation	1	1	64

Pablo J. Cagnoni

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Correlation between Development of Rash and Efficacy in Patients Treated with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib in Two Large Phase III Studies Bret Wacker, Tina Nagrani, Jacqueline Weinberg, Clinical Cancer Research	2007	381
Effects of Smoking on the Pharmacokinetics of Erlotinib Marta Hamilton, Julie Wolf, Jason Rusk, Clinical Cancer Research	2006	308
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality Ashwin Kashyap, John R. Wingard, Pablo J. Cagnoni, Biology of Blood and Marrow Transplantation	2002	225
Phase III Study of Efaproxiral As an Adjunct to Whole-Brain Radiation Therapy for Brain Metastases John H. Suh, Baldassarre Stea, Abdenour Nabid, Journal of Clinical Oncology	2005	194
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition Elizabeth Buck, Alexandra Eyzaguirre, Sharon Barr, Molecular Cancer Therapeutics	2007	188
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: A phase II study Börje S. Andersson, Ashwin Kashyap, Victor G. Gian, Biology of Blood and Marrow Transplantation	2002	187
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer Ian McNiece, Roy B. Jones, Scott I. Bearman, Blood	2000	159
Pharmacoeconomic Analysis of Liposomal Amphotericin B Versus Conventional Amphotericin B in the Empirical Treatment of Persistently Febrile Neutropenic Patients Pablo J. Cagnoni, Thomas J. Walsh, Mary M. Prendergast, Journal of Clinical Oncology	2000	153
Pharmacokinetic and Maximum Tolerated Dose Study of Micafungin in Combination with Fluconazole versus Fluconazole Alone for Prophylaxis of Fungal Infections in Adult Patients Undergoing a Bone Marrow or Peripheral Stem Cell Transplant J. Hiemenz, Pablo J. Cagnoni, David Simpson, Antimicrobial Agents and Chemotherapy	2005	150
White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. Mark S. Brown, Salomon M. Stemmer, Jack H. Simon, PubMed	1998	119

Page 1